Disclosures for "Feasibility of a Smartphone-based EEG Recording System for Neurological Evaluation in Kenya"
-
Ms. Enkhtsetseg has nothing to disclose.
-
Mr. Lehn-Schioeler has received personal compensation for serving as an employee of BrainCapture.
-
Dr. NSHIMIYIMANA has received personal compensation in the range of $0-$499 for serving as a Consultant for BRAIN CAPTURE.
-
Mr. Lehn-Schioeler has received personal compensation for serving as an employee of BrainCapture. Mr. Lehn-Schioeler has stock in BrainCapture.
-
Mr. Wambugu has received personal compensation for serving as an employee of BrainCapture Kenya.
-
Mrs. Larsen has received research support from BrainCapture ApS .
-
Prof. Beniczky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Beniczky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Beniczky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Prof. Beniczky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW. The institution of Prof. Beniczky has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE.
-
Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.